Patent | Date |
---|
Method Of Treating Breast Cancer App 20190375806 - VARLEY; Katherine E ;   et al. | 2019-12-12 |
Treating basal-like genotype cancers Grant 10,316,100 - Buchsbaum , et al. | 2019-06-11 |
Novel Read-Through Fusion Polynucleotides and Polypeptides and Uses Thereof App 20170267733 - Varley; Katherine E. ;   et al. | 2017-09-21 |
HER3 antibodies and uses thereof Grant 9,637,543 - Zhou , et al. May 2, 2 | 2017-05-02 |
Treating basal-like genotype cancers Grant 9,527,915 - Buchsbaum , et al. December 27, 2 | 2016-12-27 |
Treating Basal-Like Genotype Cancers App 20160317551 - Buchsbaum; Donald J. ;   et al. | 2016-11-03 |
Her3 Antibodies And Uses Thereof App 20140314774 - Zhou; Tong ;   et al. | 2014-10-23 |
Novel Read-Through Fusion Polynucleotides and Polypeptides and Uses Thereof App 20140162296 - Varley; Katherine E. ;   et al. | 2014-06-12 |
Targeting cancer stem cells with DR5 agonists Grant 8,703,712 - Buchsbaum , et al. April 22, 2 | 2014-04-22 |
Targeting Cancer Stem Cells App 20130004521 - Buchsbaum; Donald J. ;   et al. | 2013-01-03 |
Heterofunctional Segment-poly (ethylene Glycol) Polymers As Delivery Vehicles App 20110293515 - Safavy; Ahmad ;   et al. | 2011-12-01 |
Combinations of antibodies selective for DR5 and other therapeutic agents Grant 7,981,421 - Zhou , et al. July 19, 2 | 2011-07-19 |
Treating Basal-Like Genotype Cancers App 20110104143 - Buchsbaum; Donald J. ;   et al. | 2011-05-05 |
Combinations Of Antibodies Selective For Dr5 And Other Therapeutic Agents App 20110002887 - Kimberly; Robert P. ;   et al. | 2011-01-06 |
Combinations of antibodies selective for DR5 and other therapeutic agents Grant 7,704,502 - Zhou , et al. April 27, 2 | 2010-04-27 |
Antibody Selective For Dr4 And Uses Thereof App 20090208483 - Zhou; Tong ;   et al. | 2009-08-20 |
Combinations of Antibodies Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Other Therapeutic Agents App 20090022707 - Kimberly; Robert P. ;   et al. | 2009-01-22 |
Antibody selective for DR4 and uses thereof Grant 7,476,383 - Zhou , et al. January 13, 2 | 2009-01-13 |
Molecular Basis For The Identification Of Chemotherapy Resistance In Human Tumors And The Treatment Thereof App 20080132417 - Buchsbaum; Donald J. ;   et al. | 2008-06-05 |
Combinations of DR5 antibodies and other therapeutic agents Grant 7,279,160 - Zhou , et al. October 9, 2 | 2007-10-09 |
Viral vector driven mutant bacterial cytosine deaminase gene and uses thereof App 20070225245 - Buchsbaum; Donald J. ;   et al. | 2007-09-27 |
Cpt resistant cell line App 20070148710 - Buchsbaum; Donald J. | 2007-06-28 |
Combination radiation therapy and chemotherapy in conjunction with administration of growth factor receptor antibody App 20050281814 - Buchsbaum, Donald J. | 2005-12-22 |
Molecular chemotherapy enhancement of radiotherapy Grant 6,703,375 - Buchsbaum , et al. March 9, 2 | 2004-03-09 |
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof App 20030198637 - Zhou, Tong ;   et al. | 2003-10-23 |
Molecular chemotherapy enhancement of radiotherapy App 20030148984 - Buchsbaum, Donald J. ;   et al. | 2003-08-07 |
Molecular chemotherapy enhancement of radiotherapy Grant 6,599,909 - Buchsbaum , et al. July 29, 2 | 2003-07-29 |
Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents App 20030133932 - Zhou, Tong ;   et al. | 2003-07-17 |
Combination radiation therapy and chemotherapy in conjunction with administration of growth factor receptor antibody App 20020076408 - Buchsbaum, Donald J. | 2002-06-20 |
Radiolabeled immunotoxins App 20020048550 - Vallera, Daniel A. ;   et al. | 2002-04-25 |
Radiolabeled fusion toxins for cancer therapy Grant 6,001,329 - Buchsbaum , et al. December 14, 1 | 1999-12-14 |
Genetic induction of receptors for targeted radiotherapy Grant 5,902,583 - Buchsbaum , et al. May 11, 1 | 1999-05-11 |